Your browser doesn't support javascript.
loading
Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study.
Kirklin, J K; Naftel, D C; Bourge, R C; McGiffin, D C; Hill, J A; Rodeheffer, R J; Jaski, B E; Hauptman, P J; Weston, M; White-Williams, C.
Afiliação
  • Kirklin JK; University of Alabama at Birmingham, Birmingham, Ala 35293, USA. Jkirklin@UAB.edu
J Thorac Cardiovasc Surg ; 125(4): 881-90, 2003 Apr.
Article em En | MEDLINE | ID: mdl-12698152
ABSTRACT

BACKGROUND:

As therapeutic options evolve for advanced heart failure, the appropriate role for cardiac transplantation will require survival analyses that reflect changing trends in causes of death and patient and institutional risk profiles. Results from multi-institutional studies could be used to monitor progress in individual centers.

METHODS:

Between 1990 and 1999, 7290 patients undergoing cardiac transplantation in 42 institutions entered a formal outcomes study. Changing survival, causes of death, and patient risk profiles were analyzed. Multivariable risk-factor equations were applied to a single institution (300 primary heart transplants) to examine differences in risk-adjusted expected versus observed actuarial outcomes over time.

RESULTS:

Overall survival in the 42 institutions improved during the decade (P =.02). One- and 3-year cardiac transplant research database survival was as follows era 1 (1990-1992), 84% and 76%, respectively; era 2 (1993-1995), 85% and 79%, respectively; and era 3 (1996-1999), 85% and 79%, respectively. Causes of death changed over time. Pretransplantation risk profiles increased over time (P =.0001), with increases in reoperations, devices, diabetes, severely ill recipients, pulmonary vascular resistance, sensitization, ischemic times, donor age, and donor inotropic support. Three-year actuarial survival in a single institution was 3% less than risk-adjusted predicted survival in era 1, 1% higher than predicted in era 2, and 7% higher than predicted in era 3.

CONCLUSIONS:

Survival after cardiac transplantation is gradually improving, despite increasing risk profiles. Further improvement requires periodic re-evaluation of risk profiles and causes of death to target areas of surveillance, therapy, and research. By using these methods, progress at individual institutions can be assessed in a time-related, risk-adjusted manner that also reflects changing institutional experience, expertise, or both.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Cardiovasc Surg Ano de publicação: 2003 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Cardiovasc Surg Ano de publicação: 2003 Tipo de documento: Article País de afiliação: Estados Unidos